Liu C, Smith B M, Ajito K, Komatsu H, Gomez-Paloma L, Li T, Theodorakis E A, Nicolaou K C, Vogt P K
Department of Molecular and Experimental Medicine, Scripps Research Institute, La Jolla, CA 92037, USA.
Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):940-4. doi: 10.1073/pnas.93.2.940.
The synthetic oligosaccharide moiety of the antibiotic calicheamicin and the head-to-head dimer of this oligosaccharide are known to bind to the minor groove of DNA in a sequence-selective manner preferring distinct target sequences. We tested these carbohydrates for their ability to interfere with transcription factor function. The oligosaccharides inhibit binding of transcription factors to DNA in a sequence-selective manner, probably by inducing a conformational change in DNA structure. They also interfere with transcription by polymerase II in vitro. The effective concentrations of the oligosaccharides for inhibition of transcription factor binding and for transcriptional inhibition are in the micromolar range. The dimer is a significantly more active inhibitor than is the monomer.
已知抗生素刺孢霉素的合成寡糖部分及其寡糖的头对头二聚体以序列选择性方式结合到DNA的小沟中,偏好不同的靶序列。我们测试了这些碳水化合物干扰转录因子功能的能力。这些寡糖以序列选择性方式抑制转录因子与DNA的结合,可能是通过诱导DNA结构的构象变化。它们在体外也会干扰聚合酶II的转录。寡糖抑制转录因子结合和转录抑制的有效浓度在微摩尔范围内。二聚体是比单体活性显著更高的抑制剂。